A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Erlotinib

Need help?
media.product.imagealternatetextformat.details

Erlotinib Impurity 52

N° de SZ CAT: SZ-E018081
Número CAS
3064491-01-3
Mol.F.
C22H23N3O4
Peso Molecular
393.4
Status de Fatura
Synthesis on demand

Nome Químico: N-(2-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine

Shipping Temperature:

HSN Code: 38229010

Country of Origin: India

Sorrisos: COCCOC1=CC(C(NC(C=CC=C2)=C2C#C)=NC=N3)=C3C=C1OCCOC

Erlotinib Impurity 52 is chemically N-(2-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine. Erlotinib Impurity 52 is supplied with detailed characterization data compliant with regulatory guideline. Erlotinib Impurity 52 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erlotinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

🔍

Search by Keywords

Buy 3064491-01-3 Purchase 3064491-01-3 Order 3064491-01-3 Enquire 3064491-01-3 Price of 3064491-01-3 3064491-01-3 Supplier 3064491-01-3 Manufacturer 3064491-01-3 Exporter Buy high quality Erlotinib Impurity 52 Purchase Erlotinib Impurity 52 Erlotinib Impurity 52 suppliers Erlotinib Impurity 52 manufacturers Erlotinib Impurity 52 price Erlotinib Impurity 52 exporter Order Erlotinib Impurity 52 Enquire Erlotinib Impurity 52 Erlotinib Impurity 52 cost Erlotinib Impurity 52 Supplier Erlotinib Impurity 52 Distributor
ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

,